Jelly Roll explains living with 'severe depression'
Jelly Roll has openly discussed his problematic past including struggles with depression and substance abuse
Jelly Roll, born Jason DeFord, is known for his raw honesty about mental health, addiction, and personal struggle.
Before his rise to fame, he faced incarceration, substance use issues, and deep emotional turmoil.
However, instead of shying away from his past he has made it central to his music—turning pain into something that resonates with millions.
His Struggle with Depression
Jelly Roll has openly spoken about living with severe depression and mood instability. In interviews and social media posts, he has described experiencing emotional extremes, feelings of intense productivity followed by deep lows.
He once shared, “I struggle with severe depression,” emphasizing that mental health challenges can persist even when life appears successful.
Addiction and Rock Bottom
Alongside depression, Jelly Roll battled addiction, which became a coping mechanism for his emotional pain. His early life included time in jail, where he began to confront his actions and mental health. His music often reflects this phase, stories of regret, guilt, and a desire for redemption.
“As an addict, it was hard for me to get away from it,” he said.
Songs like Lonely Road and Amen explore themes of internal struggle, faith, and the search for meaning.
Turning His Life Around
What makes Jelly Roll’s story powerful is his transformation. He began to focus on accountability, self-forgiveness, and helping others. He has spoken about wanting to support people going through addiction and mental health struggles, even expressing plans to create spaces for recovery and healing.
Using His Platform for Awareness
Jelly Roll, now, uses his platform to advocate for mental health awareness. He consistently reminds fans that struggling does not make you weak, it’s makes you human.
-
Novo says new Ozempic shows lower cardiovascular risk compared with Lilly’s Mounjaro
-
University of Nottingham researchers say new gel could regrow tooth enamel in weeks
-
New Chinese drug extends stroke treatment window from hours to 2 days: study finds
-
Trump’s FDA nominee Heidi Overton defends vaccines, contradicting his claims
-
New once-weekly insulin injection for type 2 diabetes wins FDA approval
-
Study identifies key cause of fatigue and brain fog
-
Apple’s screenless fitness tracker plans revealed: What to know
-
Rabies concerns grow in US, sparking health warnings over fatal virus
